L-Lysine-d9 (hydrochloride)
Product Specifications
UNSPSC Description
L-Lysine-d9 (hydrochloride) is the deuterium labeled L-Lysine. L-lysine hydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health.
Target Antigen
Endogenous Metabolite; Virus Protease
Type
Isotope-Labeled Compounds
Related Pathways
Anti-infection;Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Infection
Purity
99.0
Solubility
10 mM in DMSO
Smiles
N[C@@](C(O)=O)([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])N.Cl
Molecular Weight
191.70
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Al-Malki AL, et al. Suppression of acute pancreatitis by L-lysinein mice. BMC Complement Altern Med. 2015 Jun 23;15:193.|[3]Baruffol C, et al. L-lysine dose dependently delays gastric emptying and increases intestinal fluid volume in humans and rats. Neurogastroenterol Motil. 2014 Jul;26(7):999-1009.|[4]Shimomura A, et al. Dietary L-lysineprevents arterial calcification in adenine-induced uremic rats. J Am Soc Nephrol. 2014 Sep;25(9):1954-65.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Clinical Information
No Development Reported
CAS Number
2708343-64-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS9423956-01 0.02 mg
Recombinant Human Tyrosine-protein kinase JAK1 (JAK1), partial
Ask
View Details 
MBS9423956-02 0.1 mg
Recombinant Human Tyrosine-protein kinase JAK1 (JAK1), partial
Ask
View Details 
MBS9423956-04 5x 1 mg
Recombinant Human Tyrosine-protein kinase JAK1 (JAK1), partial
Ask
View Details MBS1300025-01 0.02 mg (E-Coli)
Recombinant Anopheles gambiae Adenylyltransferase and sulfurtransferase MOCS3 (AGAP001737)
Ask
View Details